<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>College of Life Sciences</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F3117DE5-6339-4631-864F-9A58D6447D09"><gtr:id>F3117DE5-6339-4631-864F-9A58D6447D09</gtr:id><gtr:firstName>Daan</gtr:firstName><gtr:surname>van Aalten</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900138"><gtr:id>0F18A759-3001-4632-8E0E-FB23C0860724</gtr:id><gtr:title>Molecular mechanisms of fungal cell wall assembly</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900138</gtr:grantReference><gtr:abstractText>Pathogenic fungi, such as A. fumigatus and C. albicans, are widespread and most of us carry spores of these organisms. Normally our immune system is perfectly capable of suppressing the growth of these organisms. However, under conditions where the immune system is weakened, for instance during chemotheraphy, organ transplants or HIV infection, these microbes are able to establish lethal infections that are not uniformly/well treatable with currently available drugs - there is a significant unmet medical need. This proposal aims to give us an understanding of enzymes that are important for building the cell wall - a structure that protects these microbes from their environment. This work will ultimately lead to the identification of opportunities for the discovery of novel anti-fungal drugs by the pharmaceutical industry.</gtr:abstractText><gtr:technicalSummary>The fungal cell wall is a dynamic and multi-layered structure, containing a core of crosslinked chitin and glucan. Despite decades of work, there are huge gaps in our knowledge of the enzymes responsible for cell wall synthesis, modification and crosslinking. This is particularly pressing given the significant rise in fatal fungal infections of immunocompromised patients, and thus the need for novel, properly genetically/chemically validated, drug targets.

This proposal uses a multidisciplinary approach (covering genetics, biochemistry, structural biology, high throughout screening, synthetic chemistry and cell biology) to significantly advance our understanding of the function, biochemistry, inhibition and genetic/chemical validation of A. fumigatus/C. albicans enzymes involved in fungal cell wall biogenesis. The proposal covers four areas:

Cell wall synthesis - with the aims of generating overexpression systems for the membrane enzymes chitin/glucan synthase, determining their crystal structures and probing their mechanisms using novel assays/inhibitors and mutagenesis.

UDP-GlcNAc biosynthesis - with the aims of genetically validating this pathway in A. fumigatus, determining the crystal structures for these enzymes to assess exploitable differences with their human orthologues, and discover novel inhibitors through screening approaches.

Chitin modification - with the aims of genetically and chemically validating A. fumigatus chitinases and chitin deacetylases as potential drug targets and synthesis/discovery of novel inhibitors.

Crosslinking/transglycosylation - with the aims of determining the crystal structures, mechanism and substrate binding of the Gel/Gas and Crh transglycosylases, discover the first ever inhibitors for these enzymes and use these for chemical validation.

The output will be: 
1) a significant increase in our molecular understanding of fungal cell wall biogenesis enzymes, 
2) a collection of novel chemical tools for use by the fungal scientific community, and 
3) a springboard for novel antifungal drug discovery by follow-up translational research and/or the pharmaceutical industry.</gtr:technicalSummary><gtr:fund><gtr:end>2014-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2219964</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>JP Coll</gtr:description><gtr:id>76340D0B-CB1B-4C3B-AA09-74A561F634F2</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>56e1375563f589.83888758-1</gtr:outcomeId><gtr:partnerContribution>Fungal genetics, analytical cell wall analysis on cell wall biosynthesis enzymes</gtr:partnerContribution><gtr:piContribution>Structural biology, enzyme kinetics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Drug Discovery Unit</gtr:department><gtr:description>Drug discovery</gtr:description><gtr:id>BE2F9A27-EA43-4CCB-A7BD-E9D6FAB39BA9</gtr:id><gtr:impact>Discovery of hits against fungal cell wall targets</gtr:impact><gtr:outcomeId>MmNjAk6L4Ho-1</gtr:outcomeId><gtr:partnerContribution>HTS facilities and chemistry</gtr:partnerContribution><gtr:piContribution>Biological question and reagents for high throughput screens</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC-PPU Collaboration with Baldragon Academy</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0ABEC748-E0DC-47D3-A584-2B3979B4687D</gtr:id><gtr:impact>&amp;quot;The Medical Research Council's Protein Phosphorylation &amp;amp; Ubiquitylation Unit (MRCPPU), part of The University of Dundee, has prioritized public engagement in an effort to engage the general public and ensure that the research activities and breakthroughs are communicated to the community. Of equal importance in these communication efforts is educational outreach to students within the Dundee community.

Thus, during session 2014 -2015 and 2015-2016 school year, the MRC-PPU will partner with a local secondary school -- Baldragon Academy (BA). Teachers in BA's Science Department will collaborate with scientists at the MRC-PPU in an educational outreach effort (see Appendix 1). The purpose of this project is to increase interest and engagement in science and related careers. It will be starting in August 2014 with the S1 pupils.

Scientists from the unit will be working with the pupils on a monthly basis at the school during their science classes and will be providing them with opportunities to take part in various science experiments and demonstrations (aligned with Scotland's Curriculum for Excellence). The scientists are leaders in their field of research and as such come from all over the world. They are currently based in Dundee.&amp;quot;


Thus far, student have been very enthusiastic about the labs and very receptive to the volunteers. They have asked a multitude of quesitons and have even asked volunteers back to visit.</gtr:impact><gtr:outcomeId>54204ce09cd974.79483301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public outreach event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B10A3C85-9338-4C9A-BDC0-26F0415ABBF2</gtr:id><gtr:impact>&amp;quot;Magnificent microbes 2012&amp;quot; event at our local Science centre (&amp;quot;Sensation&amp;quot;). Displays on how microbes work, biotechnology and medical relevance.
I organised a display on antimicrobial drug discovery. For general public and selected school classes



Oversubscribed event, covered in local media.</gtr:impact><gtr:outcomeId>iXRXztxbh6q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public outreach event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F53B7D1A-F9B6-4C43-905D-8F667839ADCE</gtr:id><gtr:impact>&amp;quot;Magnificent microbes&amp;quot; event at our local Science centre (&amp;quot;Sensation&amp;quot;). Displays on how microbes work, biotechnology and medical relevance.
I organised a display on antimicrobial drug discovery. For general public and selected school classes.

Oversubscribed event, covered in local media.</gtr:impact><gtr:outcomeId>L9D5zk7Mcv8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Loving Science -- It's All Sugar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0427AFA2-5B05-4B2A-A5BA-0CAC78D86731</gtr:id><gtr:impact>The goal of these talks is to engage the general public about science and to build confidence in conveying this, for the speaker. In this case, Marouan from Daan's lab discussed his work on sugar residues (O-GlcNac).


The resulting talk stimulated conversation from the audience.</gtr:impact><gtr:outcomeId>54204c62bb90f9.28185325</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=E9iZkMU19Kk&amp;feature=c4-overview-vl&amp;list=PL6kJ7BgSa5IvGzsrZar2UfR6oJ1XjuUaW</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Magnificent Microbes</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B1147931-E642-47A3-B4BF-1A6842A96395</gtr:id><gtr:impact>Friday 14th March saw around 150 P6/7 children from 4 schools visit Dundee Science Centre to participate in the Magnificent Microbes day, part of the Magnificent Microbes project, a joint venture between the College of Life Sciences at the University of Dundee and Dundee Science Centre Science Learning Institute.


The children had the opportunity to meet scientists and researchers from the University of Dundee, and with them explore the magnificent world of microbes, including getting hands-on with techniques used by microbiologists. There was a wide range of activities and games to take part in, including learning about biofilms, glow-in-the-dark bacteria, discovering what microbes look like, finding out which of our favourite foods owe all they are to microbes, and an exciting opportunity to grow common microbes from their hands in a petri dish.</gtr:impact><gtr:outcomeId>54204bce94a7f9.82682599</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://blogs.glowscotland.org.uk/glowblogs/STEMcentralinmotion/2014/03/25/magnificent-microbes-at-dundee-science-centre/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Collaborative Award</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>BF2FC1F7-EAE6-4D1E-9AD1-571215BF9F6A</gtr:id><gtr:outcomeId>56e137cb8e66a1.92895690</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>GlycoBioChem</gtr:companyName><gtr:description>http://www.glycobiochem.com
This is a &amp;quot;pre-inc&amp;quot; company - being incubated within the university before formally spinning out. This company will sell reagents and software to facilitate research in the general glycobiology area.</gtr:description><gtr:id>585F96BE-9543-41DD-90B0-16FF11D7A064</gtr:id><gtr:impact>n.a.</gtr:impact><gtr:outcomeId>MqM5bAQbMhW</gtr:outcomeId><gtr:url>http://www.glycobiochem.com/</gtr:url><gtr:yearCompanyFormed>2010</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>B5D437C2-6D8A-4076-887F-E3CCAA8AB2F8</gtr:id><gtr:title>Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20747f28be8119528468228d8d4022f6"><gtr:id>20747f28be8119528468228d8d4022f6</gtr:id><gtr:otherNames>Rao FV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_15185_25_24088714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54AF2E40-1084-455A-AB47-1C8E6AB5680B</gtr:id><gtr:title>Genetic and structural validation of Aspergillus fumigatus UDP-N-acetylglucosamine pyrophosphorylase as an antifungal target.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ed41383f1ea39d4fa25fe1fdc6a5c7"><gtr:id>c3ed41383f1ea39d4fa25fe1fdc6a5c7</gtr:id><gtr:otherNames>Fang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>pm_15185_25_23750903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C24CE0F-92B2-41DF-9482-D669AB454B76</gtr:id><gtr:title>Molecular recognition: O-GlcNAc transfer: size matters.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0c63e31ab3976f0361a5c3f7f37f85c"><gtr:id>a0c63e31ab3976f0361a5c3f7f37f85c</gtr:id><gtr:otherNames>Gay LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>pm_15185_25_21321551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E5DC7D-120D-4E43-9897-99E51712277C</gtr:id><gtr:title>Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/099bbe0f73a4d2d7231d2af97dacb90b"><gtr:id>099bbe0f73a4d2d7231d2af97dacb90b</gtr:id><gtr:otherNames>Dorfmueller HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_15185_25_21095575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96AB2B3F-C323-4CB0-AB24-C14727AFC3D8</gtr:id><gtr:title>The Vibrio cholerae colonization factor GbpA possesses a modular structure that governs binding to different host surfaces.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af5e6b57f8da59450000f65c87f050fc"><gtr:id>af5e6b57f8da59450000f65c87f050fc</gtr:id><gtr:otherNames>Wong E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_15185_25_22253590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2466EF29-67A6-432F-989E-E932620D58A2</gtr:id><gtr:title>Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/099bbe0f73a4d2d7231d2af97dacb90b"><gtr:id>099bbe0f73a4d2d7231d2af97dacb90b</gtr:id><gtr:otherNames>Dorfmueller HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_15185_25_20026047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69992B13-B5EE-4705-A322-C5A2B0303FD0</gtr:id><gtr:title>Molecular mechanism of elongation factor 1A inhibition by a Legionella pneumophila glycosyltransferase.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/052161ee84550d625b142896273a2fad"><gtr:id>052161ee84550d625b142896273a2fad</gtr:id><gtr:otherNames>Hurtado-Guerrero R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>bbdTqxpRFSy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B9BE5D3-1601-4B41-A4F2-DD2DC140FB20</gtr:id><gtr:title>Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a3c5c9377eb6b17d2982d8052d8a3d"><gtr:id>77a3c5c9377eb6b17d2982d8052d8a3d</gtr:id><gtr:otherNames>Brand S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56e135f3d618f7.73604160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A39A7F5-CF8A-403C-8394-15FD1ABDE21E</gtr:id><gtr:title>Tyrosine glycosylation of Rho by Yersinia toxin impairs blastomere cell behaviour in zebrafish embryos.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb94635a593efa8fa6c327b9fa24578a"><gtr:id>bb94635a593efa8fa6c327b9fa24578a</gtr:id><gtr:otherNames>Jank T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e135f4861512.27646863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C61E45E0-3B05-42F1-9DBE-F5B5B0C07945</gtr:id><gtr:title>IQGAP proteins reveal an atypical phosphoinositide (aPI) binding domain with a pseudo C2 domain fold.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10c5072ac3714a910a28244aeee2b690"><gtr:id>10c5072ac3714a910a28244aeee2b690</gtr:id><gtr:otherNames>Dixon MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15185_25_22493426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>197D88DE-9FA6-4D6C-A803-37B200347860</gtr:id><gtr:title>Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases.</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d343e9b0b0b28248bf24cc049ea66400"><gtr:id>d343e9b0b0b28248bf24cc049ea66400</gtr:id><gtr:otherNames>Sch?ttelkopf AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>s9AgYrAmr6m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF83B35A-BBD9-4F2A-A15D-AE7700D2DF80</gtr:id><gtr:title>Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac12dfa46c116740844c796a1d6eae70"><gtr:id>ac12dfa46c116740844c796a1d6eae70</gtr:id><gtr:otherNames>Kazlauskaite A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>56e135f4b56ba5.50550078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85F5CF94-4D99-4C9B-92BD-76754D3263D7</gtr:id><gtr:title>Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51576781d6d6536e047b0f6790fb2e0a"><gtr:id>51576781d6d6536e047b0f6790fb2e0a</gtr:id><gtr:otherNames>Sutherland TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>ST87uZfVTTY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5F28CF9-C982-46DD-A0CF-71CD1FB26799</gtr:id><gtr:title>Purification, crystallization and preliminary X-ray diffraction data of UDP-galactopyranose mutase from Aspergillus fumigatus.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/450906037ce01d6a54fbd5579088974e"><gtr:id>450906037ce01d6a54fbd5579088974e</gtr:id><gtr:otherNames>Penman GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>pm_15185_25_22684076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18AA35A5-C417-4575-98C9-359228F43F52</gtr:id><gtr:title>Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide-binding properties.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc64af73d5d64b8d375c99cb214a187"><gtr:id>0fc64af73d5d64b8d375c99cb214a187</gtr:id><gtr:otherNames>Schimpl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_15185_25_22742450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D14AB257-5C6D-4F33-8D48-5849D846792F</gtr:id><gtr:title>Natural product-guided discovery of a fungal chitinase inhibitor.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358c783f9da1a951d6af6f136ffc161c"><gtr:id>358c783f9da1a951d6af6f136ffc161c</gtr:id><gtr:otherNames>Rush CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>gJoTCes359r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82845930-03FC-48AF-9146-994D4F983EC2</gtr:id><gtr:title>A novel allosteric inhibitor of the uridine diphosphate N-acetylglucosamine pyrophosphorylase from Trypanosoma brucei.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4577abec9e565c5751ac2c3823cb8c47"><gtr:id>4577abec9e565c5751ac2c3823cb8c47</gtr:id><gtr:otherNames>Urbaniak MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>pm_15185_25_23834437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FCE466F-115C-4756-847C-8D66F8C5A18B</gtr:id><gtr:title>O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cb1f90ef4952ebcde422d72eb609142"><gtr:id>6cb1f90ef4952ebcde422d72eb609142</gtr:id><gtr:otherNames>Alonso J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>546488b6690830.27191043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA2AE770-D276-4BAC-A421-0BDBF1D26157</gtr:id><gtr:title>Human OGA binds substrates in a conserved peptide recognition groove.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc64af73d5d64b8d375c99cb214a187"><gtr:id>0fc64af73d5d64b8d375c99cb214a187</gtr:id><gtr:otherNames>Schimpl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_15185_25_20863279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03991A1B-4DED-4629-86E4-9254F8DE6AB4</gtr:id><gtr:title>BslA is a self-assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bed801a510cdaa9b3689b5396a23407f"><gtr:id>bed801a510cdaa9b3689b5396a23407f</gtr:id><gtr:otherNames>Hobley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15185_25_23904481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27EECCAF-4100-405E-9EA7-55A1B35A8422</gtr:id><gtr:title>Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/338b48b933f4c81a6901b86e5d718c63"><gtr:id>338b48b933f4c81a6901b86e5d718c63</gtr:id><gtr:otherNames>Borodkin VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>546488b5beed80.20159145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>765BB3D4-5135-442F-96AF-F6CAC3809A76</gtr:id><gtr:title>Structural and functional characterization of a putative polysaccharide deacetylase of the human parasite Encephalitozoon cuniculi.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b704668ca2380f9010bd9ac04f89ab5c"><gtr:id>b704668ca2380f9010bd9ac04f89ab5c</gtr:id><gtr:otherNames>Urch JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>eB84XSsLJfE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>370B7C95-99AF-4339-9225-EDAD47058B58</gtr:id><gtr:title>Chemical tools to probe cellular O-GlcNAc signalling.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfd201469136fd731ef010c1963d3969"><gtr:id>bfd201469136fd731ef010c1963d3969</gtr:id><gtr:otherNames>Ostrowski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_15185_25_24156473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBEA2314-9077-4577-A247-9B462E81FAAE</gtr:id><gtr:title>Structural and biochemical characterization of a trapped coenzyme A adduct of Caenorhabditis elegans glucosamine-6-phosphate N-acetyltransferase 1.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/099bbe0f73a4d2d7231d2af97dacb90b"><gtr:id>099bbe0f73a4d2d7231d2af97dacb90b</gtr:id><gtr:otherNames>Dorfmueller HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>pm_15185_25_22868768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA2D654-3042-4305-82E6-526E54FF2315</gtr:id><gtr:title>Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dea3ececb33c589e299dec261a091450"><gtr:id>dea3ececb33c589e299dec261a091450</gtr:id><gtr:otherNames>Zeqiraj E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15185_15_19892943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB8DFCF1-5711-4202-8F31-0433CC17D1E3</gtr:id><gtr:title>Protein O-GlcNAcylation is required for fibroblast growth factor signaling in Drosophila.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/512e8c5cf74a8341f6c424e0b7da79d4"><gtr:id>512e8c5cf74a8341f6c424e0b7da79d4</gtr:id><gtr:otherNames>Mariappa D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>pm_15185_25_22375049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFA72F1E-B9D4-4B4A-8402-82A72725DBA4</gtr:id><gtr:title>A sweet TET-&amp;agrave;-t&amp;ecirc;te-synergy of TET proteins and O-GlcNAc transferase in transcription.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/512e8c5cf74a8341f6c424e0b7da79d4"><gtr:id>512e8c5cf74a8341f6c424e0b7da79d4</gtr:id><gtr:otherNames>Mariappa D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_15185_25_23403924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E4176EC-4A06-45B0-9D90-BEB765184578</gtr:id><gtr:title>Acetazolamide-based fungal chitinase inhibitors.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d343e9b0b0b28248bf24cc049ea66400"><gtr:id>d343e9b0b0b28248bf24cc049ea66400</gtr:id><gtr:otherNames>Sch?ttelkopf AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>JTfMzw9NWzn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3825C5C-06D8-4880-B5C0-34CA057AC3D0</gtr:id><gtr:title>O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc64af73d5d64b8d375c99cb214a187"><gtr:id>0fc64af73d5d64b8d375c99cb214a187</gtr:id><gtr:otherNames>Schimpl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>pm_15185_25_23103942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A328419C-6485-498A-B3A8-59B808597726</gtr:id><gtr:title>Screening-based discovery of Aspergillus fumigatus plant-type chitinase inhibitors.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e49789954d8db3b3b987aef44cb9fb"><gtr:id>c5e49789954d8db3b3b987aef44cb9fb</gtr:id><gtr:otherNames>Lockhart DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>546488b5eac641.36733791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A7CD224-6486-48BB-84F9-FEDD5002BDEC</gtr:id><gtr:title>The Early Metazoan Trichoplax adhaerens Possesses a Functional O-GlcNAc System.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cfcd3af5f102ab32be6446d7925b153"><gtr:id>7cfcd3af5f102ab32be6446d7925b153</gtr:id><gtr:otherNames>Selvan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56e135f4339539.77616051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46D38EDC-A34F-4BEE-B6C6-23A6E0791D22</gtr:id><gtr:title>Charge-surrounded pockets and electrostatic interactions with small ions modulate the activity of retroviral fusion proteins.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c055db1964fe97b6613983b0441b618"><gtr:id>5c055db1964fe97b6613983b0441b618</gtr:id><gtr:otherNames>Lamb D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>mDBFHJGwQoM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>862F08F3-CF8E-4E4F-B193-820815A01955</gtr:id><gtr:title>O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14183c5032f0f6dfbece3576956c8e8a"><gtr:id>14183c5032f0f6dfbece3576956c8e8a</gtr:id><gtr:otherNames>Pathak S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_15185_25_22307082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EF84656-9BDF-4080-91C0-15DB72E81CB4</gtr:id><gtr:title>GacA is essential for Group A Streptococcus and defines a new class of monomeric dTDP-4-dehydrorhamnose reductases (RmlD).</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da890623579327d3f391ec4eecd6b284"><gtr:id>da890623579327d3f391ec4eecd6b284</gtr:id><gtr:otherNames>van der Beek SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>56e135f542a901.34920975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD6003CF-54D5-4E88-ADC7-586648D40922</gtr:id><gtr:title>Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ESC differentiation without affecting na&amp;iuml;ve to primed cell transition.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8a7fad5ad4998006380245e7f0ab30a"><gtr:id>c8a7fad5ad4998006380245e7f0ab30a</gtr:id><gtr:otherNames>Speakman CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>546488b6414c71.19216497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81F58288-A9AD-4BB6-9FC6-19518293F70A</gtr:id><gtr:title>Yeast Mnn9 is both a priming glycosyltransferase and an allosteric activator of mannan biosynthesis.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f2f6a49054fb35e5f976a4f288baa41"><gtr:id>2f2f6a49054fb35e5f976a4f288baa41</gtr:id><gtr:otherNames>Striebeck A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_15185_25_24026536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEA9499D-9D7D-471C-9963-CF4AD94BEA19</gtr:id><gtr:title>Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89595fe987700a3e8abaf6a651a6ebad"><gtr:id>89595fe987700a3e8abaf6a651a6ebad</gtr:id><gtr:otherNames>Woodroof HI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_15185_25_22645651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86D5EAC6-D8FB-4849-8803-867094BDB007</gtr:id><gtr:title>An efficient and versatile synthesis of GlcNAcstatins-potent and selective O-GlcNAcase inhibitors built on the tetrahydroimidazo[1,2-a]pyridine scaffold.</gtr:title><gtr:parentPublicationTitle>Tetrahedron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/338b48b933f4c81a6901b86e5d718c63"><gtr:id>338b48b933f4c81a6901b86e5d718c63</gtr:id><gtr:otherNames>Borodkin VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-4020</gtr:issn><gtr:outcomeId>pm_15185_25_20976183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D96B1FD8-C7EC-4905-8542-12A9472B266C</gtr:id><gtr:title>ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dea3ececb33c589e299dec261a091450"><gtr:id>dea3ececb33c589e299dec261a091450</gtr:id><gtr:otherNames>Zeqiraj E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_15185_15_19513107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCBB2143-CA3F-45EA-A6CF-586CE192631D</gtr:id><gtr:title>Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfd201469136fd731ef010c1963d3969"><gtr:id>bfd201469136fd731ef010c1963d3969</gtr:id><gtr:otherNames>Ostrowski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56e135f565f7e7.43529933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A41B1350-5C00-4C31-AF17-54796AC803CF</gtr:id><gtr:title>Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8c0f9b9047e25a0efbacbe6f719692c"><gtr:id>a8c0f9b9047e25a0efbacbe6f719692c</gtr:id><gtr:otherNames>Hahne H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>pm_15185_25_23301498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8821FCE4-B709-4EF1-9AEB-A348FED5479D</gtr:id><gtr:title>N-myristoyltransferase is a cell wall target in Aspergillus fumigatus.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ed41383f1ea39d4fa25fe1fdc6a5c7"><gtr:id>c3ed41383f1ea39d4fa25fe1fdc6a5c7</gtr:id><gtr:otherNames>Fang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>56e135f458af43.18703951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B83C8D0F-0FC2-452C-8EEF-CE309C048F19</gtr:id><gtr:title>Substrate and product analogues as human O-GlcNAc transferase inhibitors.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/099bbe0f73a4d2d7231d2af97dacb90b"><gtr:id>099bbe0f73a4d2d7231d2af97dacb90b</gtr:id><gtr:otherNames>Dorfmueller HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>pm_15185_25_20640461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CB6BF60-D581-4DA3-9D48-31F3FD3ADCB4</gtr:id><gtr:title>A structural and biochemical model of processive chitin synthesis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/099bbe0f73a4d2d7231d2af97dacb90b"><gtr:id>099bbe0f73a4d2d7231d2af97dacb90b</gtr:id><gtr:otherNames>Dorfmueller HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>546488b61c2219.74749582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87BD3DB4-8166-4F5E-8105-9E6D2F364581</gtr:id><gtr:title>N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46358543a9776825d72fb7489811e0bf"><gtr:id>46358543a9776825d72fb7489811e0bf</gtr:id><gtr:otherNames>Frearson JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>nb6gXZxcU6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D08C8505-E6C2-4805-896F-6BE59AF5DD05</gtr:id><gtr:title>Synergy of peptide and sugar in O-GlcNAcase substrate recognition.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc64af73d5d64b8d375c99cb214a187"><gtr:id>0fc64af73d5d64b8d375c99cb214a187</gtr:id><gtr:otherNames>Schimpl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_15185_25_22365600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0D8AC80-A37A-4357-9A5F-3688249689AA</gtr:id><gtr:title>Pseudokinases-remnants of evolution or key allosteric regulators?</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dea3ececb33c589e299dec261a091450"><gtr:id>dea3ececb33c589e299dec261a091450</gtr:id><gtr:otherNames>Zeqiraj E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>pm_15185_25_21074407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>540381F9-63FA-466E-9D8E-0F66D39F30B8</gtr:id><gtr:title>Genetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target.</gtr:title><gtr:parentPublicationTitle>Bioscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ed41383f1ea39d4fa25fe1fdc6a5c7"><gtr:id>c3ed41383f1ea39d4fa25fe1fdc6a5c7</gtr:id><gtr:otherNames>Fang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>pm_15185_25_23844980</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900138</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>